Why the study?
Does supranormal oxygen delivery improve outcomes in high-risk non-cardiac surgical patients?
Does supranormal oxygen delivery improve outcomes in high-risk non-cardiac surgical patients?
Current evidence does not support the use of supranormal oxygen delivery in high-risk non-cardiac surgery due to flawed study designs.
Answers are grounded in this paper and cite their sources.
Does not support use in high-risk non-cardiac surgery; leaves open whether improved trial designs can clarify benefit.
The author overviews the use of supranormal oxygen delivery in high risk non-cardiac surgical patients. Major problems in the design of studies to evaluate this management exist and its use can not be supported by the evidence. (non-author abstract)
No takes yet. Share an insight, caveat, or question.
T.J. Morgan (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: